{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:17:34Z","timestamp":1760170654029,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.anl.2010.10.007","type":"journal-article","created":{"date-parts":[[2011,1,9]],"date-time":"2011-01-09T04:21:06Z","timestamp":1294546866000},"page":"312-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The effects of pegylated interferon\/lamivudine therapy on auditory functions in patients with chronic hepatitis B"],"prefix":"10.1016","volume":"38","author":[{"given":"Gulden","family":"Eser Karlidag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turgut","family":"Karlidag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kutbettin","family":"Demirdag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erol","family":"Keles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2010.10.007_bib0005","unstructured":"World Health Organization. World Health Organization Hepatitis B Fact Sheet; 1998."},{"key":"10.1016\/j.anl.2010.10.007_bib0010","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.3748\/wjg.v12.i15.2417","article-title":"Pegylated IFN-\u03b1 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B","volume":"12","author":"Vassiliadis","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.anl.2010.10.007_bib0015","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(05)17701-0","article-title":"Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial","volume":"365","author":"Janssen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2010.10.007_bib0020","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement: management of hepatitis C: June 10\u201312, 2002. Hepatology 2002;36(Suppl. 1):S3\u201320.","DOI":"10.1002\/hep.1840360703"},{"key":"10.1016\/j.anl.2010.10.007_bib0025","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1572-0241.2004.30372.x","article-title":"Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon\/ribavirin","volume":"99","author":"Formann","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anl.2010.10.007_bib0030","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.3748\/wjg.v11.i34.5392","article-title":"Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: outcome after resumption of therapy","volume":"11","author":"Wong","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.anl.2010.10.007_bib0035","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1086\/320522","article-title":"Ototoxicity associated with use of nucleoside analog reverse transcriptase inhibitors: a report of 3 possible cases and review of the literature","volume":"32","author":"Simdon","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.anl.2010.10.007_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00001432-200002000-00002","article-title":"Mitochondrial toxicity of nucleoside analogue reverse transcriptase inhibitors: a looming obstacle for long-term antiretroviral therapy?","volume":"13","author":"Brinkman","year":"2000","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.anl.2010.10.007_bib0045","series-title":"Handbook of clinical audiology","first-page":"283","article-title":"Tympanometry in clinical audiology","author":"Hall","year":"1994"},{"key":"10.1016\/j.anl.2010.10.007_bib0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.anl.2010.10.007_bib0055","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high-dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.anl.2010.10.007_bib0060","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1080\/14992020400050055","article-title":"Effects of interferon-alpha2b on hearing","volume":"43","author":"Kaygusuz","year":"2004","journal-title":"Int J Audiol"},{"key":"10.1016\/j.anl.2010.10.007_bib0065","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1017\/S0022215100142197","article-title":"Sudden hearing loss in a patient hepatitis C virus (HCV) positive on therapy with alpha-interferon: a possible autoimmune-microvascular pathogenesis","volume":"112","author":"Cadoni","year":"1998","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.anl.2010.10.007_bib0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/14992020701261413","article-title":"Sudden hearing loss in chronic hepatitis C patient suffering from Turner syndrome, treated with pegylated interferon and ribavirin","volume":"46","author":"Piekarska","year":"2007","journal-title":"Int J Audiol"},{"key":"10.1016\/j.anl.2010.10.007_bib0075","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/MEG.0b013e3282f8e583","article-title":"Interferon-alpha-2b\/ribavirin-induced vestibulocochlear toxicity with dysautonomia in a chronic hepatitis C patient","volume":"20","author":"Johnson","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.anl.2010.10.007_bib0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/00206099509071903","article-title":"Interferon-induced sudden hearing loss","volume":"34","author":"Kanda","year":"1995","journal-title":"Audiology"},{"key":"10.1016\/j.anl.2010.10.007_bib0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(02)00190-X","article-title":"Interferon-gamma production to inner ear antigens by T cells from patients with autoimmune sensorineural hearing loss","volume":"130","author":"Lorenz","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.anl.2010.10.007_bib0090","first-page":"97","article-title":"Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report","volume":"15","author":"Tunca","year":"2004","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.anl.2010.10.007_bib0095","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(94)90237-2","article-title":"Sudden hearing loss associated with interferon","volume":"343","author":"Kanda","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2010.10.007_bib0100","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.3748\/wjg.v13.i40.5411","article-title":"Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment","volume":"13","author":"Elloumi","year":"2007","journal-title":"World J Gastroenterol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814610002294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814610002294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:26:38Z","timestamp":1759951598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814610002294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0385814610002294"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2010.10.007","relation":{},"ISSN":["0385-8146"],"issn-type":[{"type":"print","value":"0385-8146"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of pegylated interferon\/lamivudine therapy on auditory functions in patients with chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2010.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}